Pablo García‐González

Author

Biomedical Research Networking Center on Neurodegenerative Diseases ORCID

Also Known As

A Corbatón-Anchuelo, A Gailhajenet, A. Gailhajenet, García-González, Pablo, Marcos R Costa, María J. Bullido, Mercè Boada, P. García González, Pablo Garcia Gonzalez, Pablo Garcia-Gonzalez

109

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

Biomedical Research Networking Center on Neurodegenerative Diseases Instituto de Salud Carlos III Fundació ACE Universitat Autònoma de Barcelona University of Cologne

About

Pablo García‐González is an author at Biomedical Research Networking Center on Neurodegenerative Diseases specializing in neurology, alzheimer's disease, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	197
2	Health Sciences	2	2	105
3	Public Health	1	1	30
4	Biostatistics	1	1	30
5	Epidemiology	1	1	30

Pablo García‐González

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
New insights into the genetic etiology of Alzheimer’s disease and related dementias Céline Bellenguez, Fahri Küçükali, Iris E. Jansen, Nature Genetics	2022	2.3K
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores Itziar de Rojas, Sonia Moreno–Grau, Niccoló Tesi, Nature Communications	2021	320
Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project Sonia Moreno–Grau, Itziar de Rojas, Isabel Hernández, Alzheimer s & Dementia	2019	171
New insights on the genetic etiology of Alzheimer’s and related dementia Céline Bellenguez, Fahri Küçükali, Iris E. Jansen, GeneticsGenetic EpidemiologyNeurochemical BiomarkersNew InsightsGeriatric Neurology	2020	90
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease Jiao Luo, Jesper Qvist Thomassen, Céline Bellenguez, JAMA Network Open	2023	88
Establishing In-House Cutoffs of CSF Alzheimer’s Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort Adelina Orellana, Pablo García‐González, Sergi Valero, International Journal of Molecular Sciences	2022	70
Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer’s disease Frederic Brosseron, Luca Kleineidam, Kishore Aravind Ravichandran, Neuron Neurodegenerative DiseasesAlzheimer's DiseaseMedicineSoluble Tam ReceptorsNeuropharmacology	2022	62
The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers Pascual Sánchez‐Juan, Sonia Moreno, Itziar de Rojas, Frontiers in Aging Neuroscience	2019	49
Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by <i>HLA-DRB1*04</i> subtypes Yann Le Guen, Guo Luo, Aditya Ambati, Proceedings of the National Academy of Sciences	2023	42
Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer’s type Pamela V. Martino Adami, Adelina Orellana, Pablo García‐González, Brain	2022	40

Page 1